THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.
has a chance of developing breast cancer in her lifetime
caused by breast cancer worldwide in 2020
diagnosed with breast cancer in 2020
Adding a new vertical in screening and diagnostics that is patient-oriented is a challenging task. It includes a collaborative effort from all stakeholders, from clinicians to scientists to patients to policy makers to payers. The EU-funded ThermoBreast project brings together multidisciplinary top experts around the world from clinical to research to technology design. The project plans to validate the clinical benefits of its novel technology in an international multicentre clinical study. To enhance stakeholder participation, it involves end users, SSH experts and a patient organisation in the co-creation of the new screening solution and assesses its health and socio-economic benefits as well as its cost effectiveness. To this end, a collaborative workplace with nine so-called work packages (WP) has been defined.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them (grant agreement no. 101096329).
Swiss participants in this project are supported by the Swiss State Secretariat for Education, Research and Innovation (contract no. 22.00518).